Cheap combo may stop pancreatitis after ERCP
NCT ID NCT07599605
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving rectal indomethacin (an anti-inflammatory drug) along with extra fluids before an ERCP procedure could prevent pancreatitis, a painful complication. The trial included 60 patients who needed ERCP. The goal was to see if this simple, low-cost approach reduces the chance of pancreas inflammation after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rectal indomethacin
- What this could lead to
- If it works, this could offer a simple, low-cost way to prevent a common complication after ERCP.
- What could go wrong
- This is a small, single-center trial with only 60 participants. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERCP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chihuahua City General Hospital "Dr. Salvador Zubirán Anchondo"
Chihuahua City, Chihuahua, 31000, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nerves before a scope: does anxiety make ERCP harder to tolerate?
- Hidden hazard: study tracks physical toll on ERCP doctors to prevent injury
- Could a simple phosphate IV ease severe pancreatitis?
- Common painkiller may prevent pancreatitis after bile duct procedure
- Researchers hunt for clues to predict deadly pancreas infection
- New oxygen method may prevent dangerous drops during ERCP